Showing results (1-10 of 4,233) with videos related to
Sort By:
Pageof 424
Clinical Pharmacology and Therapeutics|August 22, 2013
Clinical and regulatory features of drugs not initially approved by the FDAB Wang, J Avorn, A S KesselheimClinical Pharmacology and Therapeutics|June 1, 2013
Defining "innovativeness" in drug development: a systematic reviewA S Kesselheim, B Wang, J AvornClinical Pharmacology and Therapeutics|February 12, 2015
Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopeniaA Sarpatwari, J M Franklin, J Avorn, et al.Clinical Pharmacology and Therapeutics|July 21, 2012
Ethical considerations in orphan drug approval and useA S KesselheimClinical Pharmacology and Therapeutics|May 21, 2010
Permitting product liability litigation for FDA-approved drugs and devices promotes patient safetyA S KesselheimInternational Journal of Technology Assessment in Health Care|January 1, 1995
The prescription as final common pathwayJ AvornPharmacoeconomics|January 11, 2001
Post-modern drug evaluation. The deconstruction of evidence-based regulationJ AvornPageof 424